clinical trial · NCT06180083
Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray
Humanis Saglık Anonim Sirketi·phase1·completed·n = 56
Seasonal Allergic RhinitisPerennial Allergic RhinitisAzelastine Hydrochloride/ Fluticasone propionate nasal spray'DYMISTA' NASAL SPRAY
brief summary
Single dose (four sprays) bioequivalence study of Azelastine Hydrochloride/ Fluticasone Propionate 137 microgram/50 microgram Nasal Spray and 'DYMISTA' (Azelastine Hydrochloride/Fluticasone Propionate) Nasal Spray 137 microgram/50 microgram in healthy adult human subjects.
started
Mar 24, 2023
primary completion
Apr 26, 2023
completion
Jul 5, 2023
last updated
Dec 28, 2023
official title
Single Dose Bioequivalence Study of Azelastine Hydrochloride/Fluticasone Propionate 137microgram/50 Microgram Nasal Spray and DYMISTA Nasal Spray in Healthy Adult Human Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol